168 related articles for article (PubMed ID: 36688367)
1. Effects of Ablation Versus Drug Therapy on Quality of Life by Sex in Atrial Fibrillation: Results From the CABANA Trial.
Zeitler EP; Li Y; Silverstein AP; Russo AM; Poole JE; Daniels MR; Al-Khalidi HR; Lee KL; Bahnson TD; Anstrom KJ; Packer DL; Mark DB;
J Am Heart Assoc; 2023 Feb; 12(3):e027871. PubMed ID: 36688367
[TBL] [Abstract][Full Text] [Related]
2. Effect of Catheter Ablation vs Medical Therapy on Quality of Life Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial.
Mark DB; Anstrom KJ; Sheng S; Piccini JP; Baloch KN; Monahan KH; Daniels MR; Bahnson TD; Poole JE; Rosenberg Y; Lee KL; Packer DL;
JAMA; 2019 Apr; 321(13):1275-1285. PubMed ID: 30874716
[TBL] [Abstract][Full Text] [Related]
3. Influence of atrial fibrillation type on outcomes of ablation vs. drug therapy: results from CABANA.
Monahan KH; Bunch TJ; Mark DB; Poole JE; Bahnson TD; Al-Khalidi HR; Silverstein AP; Daniels MR; Lee KL; Packer DL;
Europace; 2022 Oct; 24(9):1430-1440. PubMed ID: 35640922
[TBL] [Abstract][Full Text] [Related]
4. Ablation Versus Drug Therapy for Atrial Fibrillation in Heart Failure: Results From the CABANA Trial.
Packer DL; Piccini JP; Monahan KH; Al-Khalidi HR; Silverstein AP; Noseworthy PA; Poole JE; Bahnson TD; Lee KL; Mark DB;
Circulation; 2021 Apr; 143(14):1377-1390. PubMed ID: 33554614
[TBL] [Abstract][Full Text] [Related]
5. Association Between Sex and Treatment Outcomes of Atrial Fibrillation Ablation Versus Drug Therapy: Results From the CABANA Trial.
Russo AM; Zeitler EP; Giczewska A; Silverstein AP; Al-Khalidi HR; Cha YM; Monahan KH; Bahnson TD; Mark DB; Packer DL; Poole JE;
Circulation; 2021 Feb; 143(7):661-672. PubMed ID: 33499668
[TBL] [Abstract][Full Text] [Related]
6. Recurrence of Atrial Fibrillation After Catheter Ablation or Antiarrhythmic Drug Therapy in the CABANA Trial.
Poole JE; Bahnson TD; Monahan KH; Johnson G; Rostami H; Silverstein AP; Al-Khalidi HR; Rosenberg Y; Mark DB; Lee KL; Packer DL;
J Am Coll Cardiol; 2020 Jun; 75(25):3105-3118. PubMed ID: 32586583
[TBL] [Abstract][Full Text] [Related]
7. Quality of life and healthcare utilisation improvements after atrial fibrillation ablation.
Gupta D; Vijgen J; Potter T; Scherr D; Van Herendael H; Knecht S; Kobza R; Berte B; Sandgaard N; Albenque JP; Széplaki G; Stevenhagen Y; Taghji P; Wright M; Duytschaever M
Heart; 2021 Aug; 107(16):1296-1302. PubMed ID: 33952593
[TBL] [Abstract][Full Text] [Related]
8. Association Between Age and Outcomes of Catheter Ablation Versus Medical Therapy for Atrial Fibrillation: Results From the CABANA Trial.
Bahnson TD; Giczewska A; Mark DB; Russo AM; Monahan KH; Al-Khalidi HR; Silverstein AP; Poole JE; Lee KL; Packer DL;
Circulation; 2022 Mar; 145(11):796-804. PubMed ID: 34933570
[TBL] [Abstract][Full Text] [Related]
9. Relationship between quality of life and burden of recurrent atrial fibrillation following ablation: CAPCOST multicentre cohort study.
Essebag V; Azizi Z; Alipour P; Khaykin Y; Leong-Sit P; Sarrazin JF; Sturmer M; Morillo C; Terricabras M; Amit G; Roux JF; Patterson S; Verma A
Europace; 2020 Jul; 22(7):1017-1025. PubMed ID: 32531030
[TBL] [Abstract][Full Text] [Related]
10. Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial.
Packer DL; Mark DB; Robb RA; Monahan KH; Bahnson TD; Poole JE; Noseworthy PA; Rosenberg YD; Jeffries N; Mitchell LB; Flaker GC; Pokushalov E; Romanov A; Bunch TJ; Noelker G; Ardashev A; Revishvili A; Wilber DJ; Cappato R; Kuck KH; Hindricks G; Davies DW; Kowey PR; Naccarelli GV; Reiffel JA; Piccini JP; Silverstein AP; Al-Khalidi HR; Lee KL;
JAMA; 2019 Apr; 321(13):1261-1274. PubMed ID: 30874766
[TBL] [Abstract][Full Text] [Related]
11. Effect of Catheter Ablation vs Antiarrhythmic Medication on Quality of Life in Patients With Atrial Fibrillation: The CAPTAF Randomized Clinical Trial.
Blomström-Lundqvist C; Gizurarson S; Schwieler J; Jensen SM; Bergfeldt L; Kennebäck G; Rubulis A; Malmborg H; Raatikainen P; Lönnerholm S; Höglund N; Mörtsell D
JAMA; 2019 Mar; 321(11):1059-1068. PubMed ID: 30874754
[TBL] [Abstract][Full Text] [Related]
12. Quality of life after the initial treatment of atrial fibrillation with cryoablation versus drug therapy.
Wazni O; Dandamudi G; Sood N; Hoyt R; Tyler J; Durrani S; Niebauer M; Makati K; Halperin B; Gauri A; Morales G; Shao M; Pouliot E; Kaplon RE; Nissen SE;
Heart Rhythm; 2022 Feb; 19(2):197-205. PubMed ID: 34666139
[TBL] [Abstract][Full Text] [Related]
13. Gender differences in symptoms and functional status in patients with atrial fibrillation undergoing catheter ablation.
Bazemore TC; Bolger LE; Sears SF; Sadaf MI; Gehi AK
Pacing Clin Electrophysiol; 2019 Feb; 42(2):224-229. PubMed ID: 30548873
[TBL] [Abstract][Full Text] [Related]
14. Regional differences in outcomes with ablation versus drug therapy for atrial fibrillation: Results from the CABANA trial.
Cappato R; Mark DB; Silverstein AP; Noseworthy PA; Bonitta G; Poole JE; Piccini JP; Bahnson TD; Daniels MR; Al-Khalidi HR; Lee KL; Packer DL;
Am Heart J; 2024 Apr; 270():103-116. PubMed ID: 38307365
[TBL] [Abstract][Full Text] [Related]
15. Assessment of Sex Differences in the Initial Symptom Burden, Applied Treatment Strategy, and Quality of Life in Japanese Patients With Atrial Fibrillation.
Ikemura N; Kohsaka S; Kimura T; Ueda I; Katsumata Y; Nishiyama T; Aizawa Y; Tanimoto K; Momiyama Y; Akaishi M; Mitamura H; Fukuda K; Spertus JA; Takatsuki S
JAMA Netw Open; 2019 Mar; 2(3):e191145. PubMed ID: 30924896
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Impact of Sinus Rhythm in Atrial Fibrillation Patients: Separating Rhythm Outcomes From Randomized Strategy Findings From the CABANA Trial.
Bunch TJ; Poole JE; Silverstein AP; Lee KL; Al-Khalidi HR; Hindricks G; Romanov A; Pokushalov E; Bahnson TD; Daniels MR; Piccini JP; Mark DB; Packer DL;
Circ Arrhythm Electrophysiol; 2024 May; 17(5):e012697. PubMed ID: 38629286
[TBL] [Abstract][Full Text] [Related]
17. Improvements in symptoms and quality of life in patients with paroxysmal atrial fibrillation treated with radiofrequency catheter ablation versus antiarrhythmic drugs.
Reynolds MR; Walczak J; White SA; Cohen DJ; Wilber DJ
Circ Cardiovasc Qual Outcomes; 2010 Nov; 3(6):615-23. PubMed ID: 20940250
[TBL] [Abstract][Full Text] [Related]
18. Catheter ablation vs. antiarrhythmic drugs as 'first-line' initial therapy for atrial fibrillation: a pooled analysis of randomized data.
Chen S; Pürerfellner H; Ouyang F; Kiuchi MG; Meyer C; Martinek M; Futyma P; Zhu L; Schratter A; Wang J; Acou WJ; Ling Z; Yin Y; Liu S; Sommer P; Schmidt B; Chun JKR
Europace; 2021 Dec; 23(12):1950-1960. PubMed ID: 34405878
[TBL] [Abstract][Full Text] [Related]
19. Factors Associated With Large Improvements in Health-Related Quality of Life in Patients With Atrial Fibrillation: Results From ORBIT-AF.
Steinberg BA; Holmes DN; Pieper K; Allen LA; Chan PS; Ezekowitz MD; Freeman JV; Fonarow GC; Gersh BJ; Hylek EM; Kowey PR; Mahaffey KW; Naccarelli G; Reiffel J; Singer DE; Peterson ED; Piccini JP;
Circ Arrhythm Electrophysiol; 2020 May; 13(5):e007775. PubMed ID: 32298144
[TBL] [Abstract][Full Text] [Related]
20. Association of Atrial Fibrillation Burden With Health-Related Quality of Life After Atrial Fibrillation Ablation: Substudy of the Cryoballoon vs Contact-Force Atrial Fibrillation Ablation (CIRCA-DOSE) Randomized Clinical Trial.
Samuel M; Khairy P; Champagne J; Deyell MW; Macle L; Leong-Sit P; Novak P; Badra-Verdu M; Sapp J; Tardif JC; Andrade JG
JAMA Cardiol; 2021 Nov; 6(11):1324-1328. PubMed ID: 34406350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
